SCHEMBL11935892

SCHEMBL11935892

Cc1cnc(-c2cccnc2)cc1-c1cccnc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.51
PIM1 P11309 4/20 0.49
PIM3 Q86V86 3/20 0.49
PIM2 Q9P1W9 3/20 0.49
CYP3A4 P08684 1/20 0.49
MAP4K4 O95819 1/20 0.45
LOXL2 Q9Y4K0 1/20 0.44
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
PTK2 Q05397 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CYP19A1 P11511 1/20 0.44
AKT1 P31749 2/20 0.43
AKT2 P31751 2/20 0.43
CYP2E1 P05181 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALK Q9UM73 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473704 0.83 ADORA2A (0.45) CYP2A6PIM1PIM3PIM2CYP3A4
SCHEMBL18876259 0.78 CYP2A6 (0.64) CYP2A6PIM1PIM3PIM2CYP3A4
SCHEMBL29576461 0.78 MAP4K4 (0.59) CYP2A6CYP3A4MAP4K4HSP90AA1HSP90AB1
SCHEMBL3949315 0.78 MAP4K4 (0.59) CYP2A6CYP3A4MAP4K4HSP90AA1HSP90AB1
SCHEMBL26301732 0.77 CYP2A6 (0.54) CYP2A6PIM1PIM3PIM2CYP3A4
SCHEMBL14689056 0.77 CYP2A6 (0.58) CYP2A6PIM1PIM3PIM2CYP3A4
SCHEMBL27608932 0.72 CYP2A6 (0.50) CYP2A6CYP3A4MAP4K4HSP90AA1HSP90AB1
SCHEMBL12435508 0.71 CYP2A6 (0.58) CYP2A6PIM1PIM3PIM2CYP3A4
SCHEMBL19554650 0.71 CYP2A6 (0.50) CYP2A6PIM1PIM3PIM2CYP3A4
SCHEMBL972625 0.70 NUDT1 (0.53) CYP2A6CYP3A4HSP90AA1HSP90AB1PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120208809-A1 9H-PYRROLO[2,3-B: 5,4-C'] DIPYRIDINE AZACARBOLINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208809-A1 9H-PYRROLO[2,3-B: 5,4-C'] DIPYRIDINE AZACARBOLINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF NPR3, CCNH, CBR3 CYP2A6 1471/4885PIM1 3366/4885PIM3 1252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.